Pathstone Family Office’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-209
Closed 720
2017
Q1
$0 Buy
+209
New ﹤0.01% 654